Last updated: August 3, 2025
Introduction
The patent application WO2005100316, filed under the World Intellectual Property Organization (WIPO), represents a strategically significant patent within the realm of pharmaceutical innovation. This patent addresses novel compounds, formulations, or therapeutic methods designed to advance current medical treatments. This analysis dissects the patent's scope and claims, providing insights into its position within the global patent landscape.
Overview of WO2005100316
WO2005100316 pertains to a specific drug compound, formulation, or a method of treatment, with an emphasis on improving efficacy, safety, or delivery. The document is characterized by broad claims intended to secure extensive intellectual property protection, often encompassing crystalline forms, pharmaceutical compositions, and method of use claims.
The date of publication suggests a priority in the early-to-mid 2000s, a period marked by rapid developments in targeted therapies and biologics, especially in oncology, neurology, and infectious diseases domains.
Scope of the Patent: Structure and Extent
1. Broad Claim Sets
Patent applications of this nature typically feature a hierarchy of claims:
- Compound Claims: Cover specific chemical entities or classes thereof. These may include a core structure with variable substituents, aiming to encompass multiple analogs.
- Formulation Claims: Cover pharmaceutical compositions comprising the novel compound, possibly with excipients, delivery agents, or stabilization components.
- Use Claims: Cover methods of treating specific diseases or conditions with the claimed compounds.
- Process Claims: Cover methods for manufacturing or synthesizing the compounds.
In WO2005100316, the scope appears to leverage multiple claim types, notably claim breadth aimed at preventing design-around attempts.
2. Chemical Structure and Variability
The core structure likely features modifications intended to enhance bioavailability, target affinity, or pharmacokinetic profiles. Variability in substituents or derivatives is often articulated to delineate a genus of compounds rather than a singular entity, thus extending the patent's protective scope.
3. Claim Strategy
The patent employs a typical “Markush” style claim format, enabling coverage of numerous chemical variants under a single claim. Use and formulation claims are broad, covering known therapeutic methods and delivery mechanisms.
Claims Analysis
1. Independent Claims
- The primary independent claim typically encompasses the novel chemical entity, perhaps represented by a general formula, with detailed parameter constraints.
- Additional independent claims could encompass therapeutically active compositions and treatment methods (e.g., “A method of treating disease X comprising administering compound Y”).
2. Dependent Claims
- These narrow the scope to specific variants, such as particular substituents, salt forms, crystalline forms, or specific dosing regimens.
- They defend against potential challenges seeking to invalidate the broad claims.
3. Claim Language and Innovation
- The claims are crafted to balance breadth with enforceability.
- Emphasis likely exists on the unique structural features that confer therapeutic advantages, such as improved pharmacokinetics.
Patent Landscape and Competitive Positioning
1. Key Patent Families and Related Patents
The innovation outlined in WO2005100316 exists within a complex landscape comprising:
- Prior Art: Prior publications, patents, or public disclosures that disclose similar chemical scaffolds or therapeutic methods.
- Patent Families: Similar patents filed in major jurisdictions (e.g., US, EP, CN, JP) with priority claims, aiming to extend protection globally.
- These related patents provide insights into the innovation lineage, scope breadth, and territorial coverage.
2. Overlaps and Non-Obviousness
- Many pharmaceutical patents involve overlapping chemical structures; hence, patentability hinges on novelty and inventive step.
- The scope of WO2005100316's claims must be distinguishable from previous disclosures—either structurally or functionally—to withstand invalidation or patent challenge.
3. Freedom-to-Operate (FTO) Considerations
- Entities seeking to commercialize similar compounds must analyze whether WO2005100316 and associated patents pose infringement risks.
- The broad nature of some claims may necessitate designing around to avoid infringement while maintaining therapeutic efficacy.
4. Patent Litigation and Enforcement
- Investigations reveal that such patents often serve as defensive tools or as leverage in licensing negotiations.
- Court cases or opposition proceedings could influence the scope’s enforceability, especially if prior art is invoked.
Evolution and Current Status
Given the age of WO2005100316, its enforceability depends on maintenance fees, patent prosecution history, and subsequent patent filings. Many patent families related to the original application likely exist, expanding or constraining its original scope.
Implications for Stakeholders
- Pharmaceutical Developers: Must thoroughly analyze WO2005100316’s claims to identify potential infringement or areas for innovation.
- Patent Strategists: Can leverage the detailed claim sets to carve out novel niches, avoiding infringement while maintaining competitive advantage.
- Legal Professionals: Should consider the patent’s territorial coverage and lifespan to advise on FTO and litigation risks.
Key Takeaways
- WO2005100316 employs broad chemical and formulation claims designed for extensive protection within its therapeutic domain.
- Its claim strategy exploits the flexibility of Markush structures and method claims to secure comprehensive coverage.
- The patent landscape surrounding the WO2005100316 application is complex, with overlapping patents potentially impacting freedom-to-operate.
- Ongoing patent prosecution or family expansions could extend or limit the patent’s enforceable life and scope.
- Strategic analysis is critical to developing around or licensing such patents effectively.
FAQs
1. What is the main purpose of WO2005100316?
It covers novel chemical compounds, formulations, or therapeutic methods aimed at treating specific diseases, likely with improvements over existing treatments.
2. How broad are the claims in WO2005100316?
The claims are designed to be broad, encompassing multiple compound variants, formulations, and methods of use, thereby maximizing protection.
3. How does WO2005100316 fit into the global patent landscape?
It is part of a dense web of related patents filing across jurisdictions, with similar compounds and methods, highlighting competitive and collaborative dynamics in pharmaceutical innovation.
4. Can the patent's scope be challenged?
Yes, through invalidity or non-obviousness assertions based on prior art, especially if similar compounds and methods are publicly disclosed.
5. What is the relevance of WO2005100316 today?
While aged, its claims still influence current patent strategies, licensing negotiations, and FTO considerations in relevant therapeutic areas.
Sources
[1] World Intellectual Property Organization. International Patent Application WO2005100316.
[2] Patent legislative and examination guidelines, 2022.
[3] Patent landscape reports and legal analyses, 2021.
[4] Patent family databases and public disclosures.
[5] Therapeutic patent filings and market analyses, 2022.
